Advertisement Why, When and How to Conduct 14C Human Studies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, the conduct of a radiolabeled human ADME study is recognised to be necessary in order to fulfil the requirements of the last guidance on safety testing of drug metabolism. To find out more, please download this free white paper.

Download whitepaper

Enter your details to get your free whitepaper:


Submit

I have read and accept the terms and conditions and privacy policy.

receive-email We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

third-party If you would like to hear from carefully selected third party companies, check this box.

company-follow Follow this company to receive notifications when they update.


More from